Purchase Order 75N90025P00515
Award Date
6/13/25
Potential Completion Date
7/12/25
Potential Value
$12K
Federal Agency
NIH Clinical Center
Awardee
Takara Bio Usa, Inc.
Ultimate Awardee
Not listed
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95131, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health (NIH) Clinical Center awarded a firm fixed price purchase order to Takara Bio USA, Inc. to supply specialized reagents, including the RetroNectin product, to support cellular therapy manufacturing at the NIH Clinical Center. The $188,757.80 contract has a period of performance from March 1, 2019 to September 30, 2019 and is not designated as a set-aside. Takara Bio USA, Inc. is a for-profit manufacturer that has provided...
This is a firm-fixed-price delivery order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract, worth $12,600.00, was awarded to Takara Bio USA, Inc., a for-profit manufacturer of specialized biomedical products and services. The contract is for the provision of GMP (Good Manufacturing Practice) grade RetroNectin, a proprietary recombinant human fibronectin...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $30,672 purchase order to Takara Bio Usa, Inc. for the delivery of RETRONECTIN GMP GRADE REAGENT. Performance will take place in San Jose, California over a period of approximately two months from December 2023 through February 2024. As the prime contractor, Takara Bio Usa, Inc. will provide the requested biomedical products to support the NIH Clinical Center's medical research efforts. No...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Takara Bio USA, Inc., a prominent provider of specialized biomedical products and services to the U.S. federal government. The contract, valued at $2,508.00, is for the supply of various genomics, cell biology, and molecular diagnostics tools, including products such as SmartScribe Reverse Transcriptase, SeqAmp DNA Polymerase, and RetroNectin GMP Grade Reagent. These products...
Takara Bio USA, Inc. was awarded a firm fixed-price purchase order valued at forty-six thousand eight dollars by the Department of Health and Human Services' National Institutes of Health Clinical Center. Under this contract, Takara Bio will provide Retronectin GMP Grade Reagent to the agency. The place of performance is in San Jose, California and the period of performance concludes on February 9, 2024. No set-aside designation was applied to this award to procure the requested biomedical...
This is a $35,231.70 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Takara Bio USA, Inc. for the delivery of SMARTSCRIBE Reverse Transcriptase and SEQAMP DNA Kits. The contract does not have a set-aside designation. Takara Bio USA, Inc. is a for-profit manufacturer of biomedical products and reagents, frequently serving as a prime contractor on NIH, Environmental Protection...
The Department of Health and Human Services National Institutes of Health Clinical Center (NIH CC) awarded a firm fixed-price purchase order to Takara Bio USA, Inc. for the delivery of 154 vials of the RetroNectin reagent, which is used in the NIH CC's cellular therapy programs. This purchase order, valued at $188,796.30, was issued as a non-competitive award without full and open competition under simplified acquisition procedures. The NIH CC determined that Takara Bio USA, Inc. was the sole...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Takara Bio USA, Inc. The contract, valued at $19,975.65, is for the procurement of SMARTSEQ reagents (AMBIS #2226785) to support the agency's biomedical research activities. Takara Bio USA, a prominent manufacturer of specialized life sciences products, has a long-standing relationship with federal...
This is a firm fixed-price purchase order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency within the National Institutes of Health (NIH), to Takara Bio USA, Inc. The contract, valued at $24,900.00, is for the provision of ICELL8 service for a one-year period from June 16, 2025 to June 15, 2026. Takara Bio USA, Inc. is a for-profit manufacturer of biomedical products and life sciences research tools, with a focus on...
This is a $6,327.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Takara Bio USA, Inc., a prominent provider of specialized biomedical products and services to the federal government. The contract, which was not set aside for small businesses, is for the delivery of AMBIS # 1743568 KIT, a product that likely supports advanced research in areas such as infectious diseases,...